Prevalence of obesity and metabolic syndrome in Taiwan

Lee Ching Hwang, Chyi Huey Bai, Chien Jen Chen

Research output: Contribution to journalArticle

209 Citations (Scopus)

Abstract

Background/Purpose: Obesity and metabolic syndrome (MS) are major risk factors for the development of type 2 diabetes and cardiovascular diseases (CVD). This study estimated the prevalence of obesity and MS in Taiwan. Methods: Data from a nationwide cross-sectional population-based survey of 5936 participants (2815 men, 3121 women; age range, 20-79.9 years) in 2002 were analyzed. Obesity was defined as a body mass index (BMI) ≥ 27 kg/m2 according to the criteria of the Department of Health in Taiwan. The prevalence of MS was estimated using the definitions of the modified Adult Treatment Panel III (ATP III), the International Diabetes Federation for Chinese (MS-IDF(C)) and the MS criteria for Taiwanese (MS-TW). Results: The overall prevalence of obesity in men was significantly greater than in women (19.2% vs. 13.4%, p <0.0001). The age-standardized prevalence of MS was 15.7% by the modified ATh III criteria, 14.3% by the MS-IDF(C) criteria and 16.4% by the MS-TW criteria. The prevalence of obesity and MS significantly increased with age (trend test, p <0.0001) in men and women. The risk of MS and its components increased significantly with BMI, and showed a marked increase with BMI ≥ 24kg/m2. MS as classified by the MS-IDF(C) criteria failed to identify subjects at high risk of CVD who did not have abdominal obesity, including those with hypertension, type 2 diabetes and dyslipidemia. Conclusion: This study found a high prevalence of obesity and MS in Taiwan. The definitions of MS by the modified ATh III and MS-TW criteria were better able to detect high CVD risk than the MS-IDF(C) criteria.

Original languageEnglish
Pages (from-to)626-635
Number of pages10
JournalJournal of the Formosan Medical Association = Taiwan yi zhi
Volume105
Issue number8
Publication statusPublished - Aug 2006
Externally publishedYes

Fingerprint

Taiwan
Obesity
Body Mass Index
Cardiovascular Diseases
Type 2 Diabetes Mellitus
Abdominal Obesity
Dyslipidemias

Keywords

  • Body mass index
  • Metabolic syndrome
  • Obesity
  • Prevalence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Prevalence of obesity and metabolic syndrome in Taiwan. / Hwang, Lee Ching; Bai, Chyi Huey; Chen, Chien Jen.

In: Journal of the Formosan Medical Association = Taiwan yi zhi, Vol. 105, No. 8, 08.2006, p. 626-635.

Research output: Contribution to journalArticle

@article{525bd83124ee41e5b4c637d544d4ba40,
title = "Prevalence of obesity and metabolic syndrome in Taiwan",
abstract = "Background/Purpose: Obesity and metabolic syndrome (MS) are major risk factors for the development of type 2 diabetes and cardiovascular diseases (CVD). This study estimated the prevalence of obesity and MS in Taiwan. Methods: Data from a nationwide cross-sectional population-based survey of 5936 participants (2815 men, 3121 women; age range, 20-79.9 years) in 2002 were analyzed. Obesity was defined as a body mass index (BMI) ≥ 27 kg/m2 according to the criteria of the Department of Health in Taiwan. The prevalence of MS was estimated using the definitions of the modified Adult Treatment Panel III (ATP III), the International Diabetes Federation for Chinese (MS-IDF(C)) and the MS criteria for Taiwanese (MS-TW). Results: The overall prevalence of obesity in men was significantly greater than in women (19.2{\%} vs. 13.4{\%}, p <0.0001). The age-standardized prevalence of MS was 15.7{\%} by the modified ATh III criteria, 14.3{\%} by the MS-IDF(C) criteria and 16.4{\%} by the MS-TW criteria. The prevalence of obesity and MS significantly increased with age (trend test, p <0.0001) in men and women. The risk of MS and its components increased significantly with BMI, and showed a marked increase with BMI ≥ 24kg/m2. MS as classified by the MS-IDF(C) criteria failed to identify subjects at high risk of CVD who did not have abdominal obesity, including those with hypertension, type 2 diabetes and dyslipidemia. Conclusion: This study found a high prevalence of obesity and MS in Taiwan. The definitions of MS by the modified ATh III and MS-TW criteria were better able to detect high CVD risk than the MS-IDF(C) criteria.",
keywords = "Body mass index, Metabolic syndrome, Obesity, Prevalence",
author = "Hwang, {Lee Ching} and Bai, {Chyi Huey} and Chen, {Chien Jen}",
year = "2006",
month = "8",
language = "English",
volume = "105",
pages = "626--635",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Elsevier Science Publishers B.V.",
number = "8",

}

TY - JOUR

T1 - Prevalence of obesity and metabolic syndrome in Taiwan

AU - Hwang, Lee Ching

AU - Bai, Chyi Huey

AU - Chen, Chien Jen

PY - 2006/8

Y1 - 2006/8

N2 - Background/Purpose: Obesity and metabolic syndrome (MS) are major risk factors for the development of type 2 diabetes and cardiovascular diseases (CVD). This study estimated the prevalence of obesity and MS in Taiwan. Methods: Data from a nationwide cross-sectional population-based survey of 5936 participants (2815 men, 3121 women; age range, 20-79.9 years) in 2002 were analyzed. Obesity was defined as a body mass index (BMI) ≥ 27 kg/m2 according to the criteria of the Department of Health in Taiwan. The prevalence of MS was estimated using the definitions of the modified Adult Treatment Panel III (ATP III), the International Diabetes Federation for Chinese (MS-IDF(C)) and the MS criteria for Taiwanese (MS-TW). Results: The overall prevalence of obesity in men was significantly greater than in women (19.2% vs. 13.4%, p <0.0001). The age-standardized prevalence of MS was 15.7% by the modified ATh III criteria, 14.3% by the MS-IDF(C) criteria and 16.4% by the MS-TW criteria. The prevalence of obesity and MS significantly increased with age (trend test, p <0.0001) in men and women. The risk of MS and its components increased significantly with BMI, and showed a marked increase with BMI ≥ 24kg/m2. MS as classified by the MS-IDF(C) criteria failed to identify subjects at high risk of CVD who did not have abdominal obesity, including those with hypertension, type 2 diabetes and dyslipidemia. Conclusion: This study found a high prevalence of obesity and MS in Taiwan. The definitions of MS by the modified ATh III and MS-TW criteria were better able to detect high CVD risk than the MS-IDF(C) criteria.

AB - Background/Purpose: Obesity and metabolic syndrome (MS) are major risk factors for the development of type 2 diabetes and cardiovascular diseases (CVD). This study estimated the prevalence of obesity and MS in Taiwan. Methods: Data from a nationwide cross-sectional population-based survey of 5936 participants (2815 men, 3121 women; age range, 20-79.9 years) in 2002 were analyzed. Obesity was defined as a body mass index (BMI) ≥ 27 kg/m2 according to the criteria of the Department of Health in Taiwan. The prevalence of MS was estimated using the definitions of the modified Adult Treatment Panel III (ATP III), the International Diabetes Federation for Chinese (MS-IDF(C)) and the MS criteria for Taiwanese (MS-TW). Results: The overall prevalence of obesity in men was significantly greater than in women (19.2% vs. 13.4%, p <0.0001). The age-standardized prevalence of MS was 15.7% by the modified ATh III criteria, 14.3% by the MS-IDF(C) criteria and 16.4% by the MS-TW criteria. The prevalence of obesity and MS significantly increased with age (trend test, p <0.0001) in men and women. The risk of MS and its components increased significantly with BMI, and showed a marked increase with BMI ≥ 24kg/m2. MS as classified by the MS-IDF(C) criteria failed to identify subjects at high risk of CVD who did not have abdominal obesity, including those with hypertension, type 2 diabetes and dyslipidemia. Conclusion: This study found a high prevalence of obesity and MS in Taiwan. The definitions of MS by the modified ATh III and MS-TW criteria were better able to detect high CVD risk than the MS-IDF(C) criteria.

KW - Body mass index

KW - Metabolic syndrome

KW - Obesity

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=33748502537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748502537&partnerID=8YFLogxK

M3 - Article

VL - 105

SP - 626

EP - 635

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 8

ER -